New 14-membered octaazamacrocyclic complexes: synthesis, spectral, antibacterial and antifungal studies.

Department of Chemistry, National Institute of Technology, Kurukshetra 136 119, India.
European journal of medicinal chemistry (Impact Factor: 3.27). 03/2010; 45(3):1230-6. DOI: 10.1016/j.ejmech.2009.12.009
Source: PubMed

ABSTRACT A novel series of macrocyclic complexes of the type [M(C(18)H(14)N(10)S(2))X]X(2) where M=Cr(III), Fe(III) and Mn(III); X=Cl(-), NO(3)(-) and CH(3)COO(-) have been synthesized by [2+2] condensation of thiocarbohydrazide and isatin in the presence of trivalent metal salts in methanolic medium by template method. The complexes have been characterized with the help of elemental analyses, conductance measurements, magnetic measurements, electronic, NMR, IR and mass spectral studies. On the basis of these studies, a five coordinate square pyramidal geometry for all of these complexes has been proposed. These metal complexes were also tested for their in vitro antimicrobial activities against some bacterial strains viz. Staphylococcus aureus, Bacillus subtilis, Escherichia coli, Pseudomonas aeruginosa and some fungal strains Aspergillus niger, Aspergillus flavus (molds), Candida albicans, Saccharomyces cerevisiae (yeasts).

1 Bookmark
  • [Show abstract] [Hide abstract]
    ABSTRACT: A series of novel 1-(substituted benzylidene)-4-(1-(morpholino/piperidino methyl)-2,3-dioxoindolin-5-yl) semicarbazides 6a-6t was designed and synthesized on the basis of semicarbazide-based pharmacophoric model to meet the structural requirements necessary for anticonvulsant activity. The compounds were subjected to in vivo antiepileptic evaluation using maximal electroshock test and subcutaneous pentylenetetrazole seizure test methods. The neurotoxicity was determined by rotorod test. In the preliminary screening, compounds 6c, 6d, 6g, 6h, and 6m were found active in maximal electroshock test model, while 6g, 6i, 6m, and 6o showed significant antiepileptic activity in subcutaneous pentylenetetrazole seizure test model. Further, the compounds 6c, 6d, 6g, 6h, 6i, and 6m were administered orally to rats, of which 6c and 6g showed better activity than phenytoin. Among the synthesized compounds, 6g revealed excellent protection in both models with lower neurotoxicity.
    Chemical Biology &amp Drug Design 04/2012; 80(4):524-32. · 2.47 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: A series of eighteen new 1-(4-substituted benzylidene)-4-(1-(substituted methyl)-2,3-dioxoindolin-5-yl)semicarbazide derivatives were designed, synthesized and characterized by spectral and elemental analyses. The derivatives were screened in vitro for antimicrobial activity against Mycobacterium tuberculosis H37Rv (ATCC 27294) and MDR-TB strains. The activity was expressed as the minimum inhibitory concentration in μg/mL. Among the tested compounds 7j, 7m, 7o and 7q possesses equipotent activity as standard drug Isoniazid against MTB while 7m and 7q exhibited higher activity against MDR-TB strain when compared with both the reference drugs isoniazid and rifampicin. Basic structure activity relationships are presented.
    Archives of Pharmacal Research 02/2013; · 1.54 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: New complexes [FeO(DMBG)]2 and [Fe(DMBG)2]Cl·0.5H2O (HDMBG: N,N-dimethylbiguanide) have been synthesized and characterized by microanalytical, IR and UV–Vis data. Electronic spectra of the complexes are characteristic for a tetrahedral stereochemistry, whilst the modifications in the IR spectra indicate the presence of the DMBG anion as chelate. The thermal decomposition investigated in air by thermal analysis confirmed the proposed formulas for the complexes and provided information concerning the modifications during heating and also the thermodynamic effects accompanying them. The thermal transformations are complex, according to TG and DTG curves including dehydration, hydrochloric acid elimination, oxidative degradation and condensation of –C=N– unit. The final product of decomposition was iron (III) oxide as powder XRD indicates. Complexes were screened for their antimicrobial properties against Gram-positive, Gram-negative bacterial, as well as fungal pathogenic strains. The results indicate that Fe(III) complexes exhibit an improved antibacterial activity against S. aureus and E. coli strains in comparison with free biguanide. The Fe(III) complexes also inhibit the ability of S. aureus, B. subtilis, P. aeruginosa and E. coli strains to colonize the inert substratum, accounting for their possible use as anti-biofilm agents.
    Journal of Thermal Analysis and Calorimetry 01/2013; 111(3). · 1.98 Impact Factor